Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

UK doctors don't have time for reps but are making time for digital

Doctors.net.uk research finds half of GPs don’t see pharma sales reps

Time-pressured GPs in the UK are refusing to see pharmaceutical sales reps and turning to online channels to conduct product research, according to a new study.

Doctors.net.uk surveyed more than 1,000 GPs in April this year and found 52 per cent of GPs did not see any pharmaceutical sales representatives in a typical week, while 26 per cent only saw one pharma sales rep during that period.

Lack of time was the most common reason cited by GPs for not seeing pharma sales reps (38 per cent), but other reasons given included practice policy and a perceived lack of reps' impartiality.

At the same time the UK online doctors' network said doctors are turning to digital channels for independent product information.

Nearly a quarter (23 per cent) of the GPs surveyed said they preferred to find their own product information via “independent online resources”.

The research would appear to be inline with more general trends among healthcare professionals for content consumption and interaction.

European online physician networks continue to see significant growth, a trend that has been particularly pronounced in the UK – along with Germany and Scandinavia.

Meanwhile, European doctors' use of iPads and other mobile devices is increasing, and in March a survey by Booz & Co found European and US pharma execs expects to increase their future spending on digital marketing channels.

Doctors.net.uk said its findings follow earlier studies it conducted that show only 3 per cent of doctors think online pharma resources are credible and 42 per cent never visit pharmaceutical websites.

16th August 2012

From: Marketing

Share


Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Portland

Portland Health supports organisations in the health and well-being, pharmaceutical and social care sectors as they adapt to the challenges...

Latest intelligence

England’s clinical commissioning landscape
Who are the real masters in the new NHS?...
How will the new landscape of Hep C treatments affect patients?
The development of new therapeutic agents is set to transform the treatment of hepatitis C over the coming years....
Pharma deal watch - handshake
Pharma deals during March 2014
Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month...